Sooma tDCS
2 790,00€
Sooma tDCS Device Features
In the USA, Sooma tDCS is labeled as an investigational device. Its use is limited to researchers or medical doctors. In the EU, Sooma tDCS adds a new dimension to the clinical routine for treating patients with major depression or chronic pain. Sooma tDCS delivery kit includes all you need to get started with your tDCS trials.
-
Description
-
Reviews (0)
Sooma tDCS Device Features
In the USA, Sooma tDCS is labeled as an investigational device. Its use is limited to researchers or medical doctors. In the EU, Sooma tDCS adds a new dimension to the clinical routine for treating patients with major depression or chronic pain. Sooma tDCS delivery kit includes all you need to get started with your tDCS trials.
- Safe and well tolerated
- Effective
- Easy to use, designed for clinical routine or research studies
- Affordable and cost-effective
- Can be used as monotherapy or as adjunct to other treatments
Device specifications
- Adjustable current up to 3 mA in increments of 0.1 mA
- Adjustable application time up to 30 min in increments of 30 sec
- Current ramp up / ramp down: 0.1 mA/s
- Maximum output voltage: 18 V
- Battery life: 100 hours. User replaceable.
- Single-button session control
- Compact size: 12 cm x 7.3 cm x 2.2 cm
- Weight (incl. batteries): 0.2 kg
- Touch-proof electrode connection in accordance with DIN 42802
- Ingress protection: IP21
How to Use Sooma tDCS
When starting a session, two electrodes are positioned over the stimulation area using a head cap that offers the intuitive usability required in clinical routine. The device ensures that the contact between scalp and electrodes is acceptable. When acceptable contact is achieved, the device allows the user to start the stimulation. Sooma offers several sizes of head caps to accommodate to different head sizes. The whole treatment preparation usually takes less than 5 minutes.
During a stimulation session, direct current is applied directly to the scalp at the stimulation area. The current intensity is 2 mA, which is 400 to 500 times less than in traditional electroconvulsive therapy (ECT).
Reviews
There are no reviews yet.